Medisca's Hair Care Compounding Solutions

Download in electronic PDF format for $25

Search the Complete Journal Archives

New Perspectives on Vancomycin Use in Home Care, Part 1

Author(s):  Kastango Eric S, Hadaway Lynn

Issue:  Nov/Dec 2001 - High-Tech Compounding
View All Articles in Issue

Abstract:  With the advent of new venous access devices (VADs) and medication delivery technology, pharmacists must reconsider the historical literature and administration guidelines that pertain to vancomycin. Current literature1-3 supports the conclusion that there is no direct correlation between vancomycin concentration or rate of administration and side effects (particularly red man syndrome). Venous access devices such as midclavicular catheters, midlines, and peripheral inserted central catheters (PICCs) enable more concentrated solutions of vancomycin to be infused safely without an increased incidence of adverse events. Advances in medication delivery technology ensure the consistency of therapy protocols (including catheter flushing and administration rate) that reduce the potential for adverse events and medication errors, particularly in the unmonitored home setting.

The American Society of Health-System Pharmacists4 states that by fulfilling their responsibilities in pharmaceutical care, pharmacists have a role in meeting the primary care needs of patients. Pharmaceutical care is the direct, responsible provision of medicationrelated care to achieve an outcome that improves a patient’s quality of life. Pharmacists establish relationships with patients to ensure the appropriateness of medication therapy, to verify patients’ understanding of that therapy, and to monitor the effects of treatment. In collaborative drug therapy management, physicians and other prescribers authorize pharmacists to select appropriate medication therapies and regimens and adjust them on the basis of patients’ responses to treatment.

The delivery of pharmaceutical care requires specialized knowledge about pharmacology, vascular access devices and their placement, compounding factors (eg, osmolarity, pH, stability, particulate matter), delivery systems, and patient management. In this article, those factors will be addressed with respect to optimizing the medication delivery of and patient response to vancomycin therapy.

Related Keywords: Catheters, peripheral, characteristics of, Vancomycin, in home care, Vancomycin, infusions, rate of administration, Vancomycin, solutions, osmolarity of, Vancomycin, solutions, pH of, Vancomycin, solutions, stability of


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
New Perspectives on Vancomycin Use in Home Care, Part 1 Kastango Eric S, Hadaway Lynn Nov/Dec 2001 465-469 Buy
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Kastango Eric S, Hadaway Lynn Jan/Feb 2002 55 Buy
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Allen Loyd V Jr, Stiles M Lou Mar/Apr 1997 123-124 Buy
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr Sep/Oct 2010 421 Buy
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Baker Daniel S, Waldrop Bruce, Arnold John Jul/Aug 2010 346-349 Buy
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M Jul/Aug 2016 347-350 Buy
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Puertos Enrique, Spencer Melissa Jul/Aug 2015 334-336 Buy
Vancomycin 31-mg/mL Ophthalmic Solution Allen Loyd V Jr Nov/Dec 2011 508 Buy
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Allen Loyd V Jr Jan/Feb 2016 56 Buy
Vancomycin HCl 50-mg/mL Oral Solution Allen Loyd V Jr Jan/Feb 2003 64 Buy